309 related articles for article (PubMed ID: 28202740)
1. Health Equity Considerations for Developing and Reporting Patient-reported Outcomes in Clinical Trials: A Report from the OMERACT Equity Special Interest Group.
Petkovic J; Barton JL; Flurey C; Goel N; Bartels CM; Barnabe C; de Wit MPT; Lyddiatt A; Lacaille D; Welch V; Boonen A; Shea B; Christensen R; Maxwell LJ; Campbell W; Jull J; Toupin-April K; Singh JA; Goldsmith CH; Sreih AG; Pohl C; Hofstetter C; Beaton DE; Buchbinder R; Guillemin F; Tugwell PS
J Rheumatol; 2017 Nov; 44(11):1727-1733. PubMed ID: 28202740
[TBL] [Abstract][Full Text] [Related]
2. Including health equity considerations in development of instruments for rheumatology research: an introduction to a novel OMERACT paradigm.
O'Neill J; Rader T; Guillemin F; Boonen A; Christensen R; Lyddiatt A; Pardo JP; Welch V; Singh JA; Tugwell P
J Rheumatol; 2014 Jan; 41(1):150-2. PubMed ID: 24128775
[TBL] [Abstract][Full Text] [Related]
3. How to choose core outcome measurement sets for clinical trials: OMERACT 11 approves filter 2.0.
Boers M; Kirwan JR; Gossec L; Conaghan PG; D'Agostino MA; Bingham CO; Brooks PM; Landewé R; March L; Simon L; Singh JA; Strand V; Wells GA; Tugwell P
J Rheumatol; 2014 May; 41(5):1025-30. PubMed ID: 24584913
[TBL] [Abstract][Full Text] [Related]
4. PsAID12 Provisionally Endorsed at OMERACT 2018 as Core Outcome Measure to Assess Psoriatic Arthritis-specific Health-related Quality of Life in Clinical Trials.
Orbai AM; Holland R; Leung YY; Tillett W; Goel N; Christensen R; McHugh N; Gossec L; de Wit M; Højgaard P; Coates LC; Mease PJ; Birt J; Fallon L; FitzGerald O; Ogdie A; Shea B; Strand V; Duffin KC; Tugwell P; Beaton D; Gladman DD
J Rheumatol; 2019 Aug; 46(8):990-995. PubMed ID: 30554154
[TBL] [Abstract][Full Text] [Related]
5. Evidence for Updating the Core Domain Set of Outcome Measures for Juvenile Idiopathic Arthritis: Report from a Special Interest Group at OMERACT 2016.
Morgan EM; Riebschleger MP; Horonjeff J; Consolaro A; Munro JE; Thornhill S; Beukelman T; Brunner HI; Creek EL; Harris JG; Horton DB; Lovell DJ; Mannion ML; Olson JC; Rahimi H; Gallo MC; Calandra S; Ravelli A; Ringold S; Shenoi S; Stinson J; Toupin-April K; Strand V; Bingham CO
J Rheumatol; 2017 Dec; 44(12):1884-1888. PubMed ID: 28811355
[TBL] [Abstract][Full Text] [Related]
6. OMERACT Filter Evidence Supporting the Measurement of At-work Productivity Loss as an Outcome Measure in Rheumatology Research.
Beaton DE; Dyer S; Boonen A; Verstappen SM; Escorpizo R; Lacaille DV; Bosworth A; Gignac MA; Leong A; Purcaru O; Leggett S; Hofstetter C; Peterson IF; Tang K; Fautrel B; Bombardier C; Tugwell PS
J Rheumatol; 2016 Jan; 43(1):214-22. PubMed ID: 26329339
[TBL] [Abstract][Full Text] [Related]
7. Instrument Selection Using the OMERACT Filter 2.1: The OMERACT Methodology.
Beaton DE; Maxwell LJ; Shea BJ; Wells GA; Boers M; Grosskleg S; Bingham CO; Conaghan PG; D'Agostino MA; de Wit MP; Gossec L; March LM; Simon LS; Singh JA; Strand V; Tugwell P
J Rheumatol; 2019 Aug; 46(8):1028-1035. PubMed ID: 30709952
[TBL] [Abstract][Full Text] [Related]
8. Outcome Measures in Rheumatology - Interventions for medication Adherence (OMERACT-Adherence) Core Domain Set for Trials of Interventions for Medication Adherence in Rheumatology: 5 Phase Study Protocol.
Kelly A; Tong A; Tymms K; March L; Craig JC; De Vera M; Evans V; Hassett G; Toupin-April K; van den Bemt B; Teixeira-Pinto A; Alten R; Bartlett SJ; Campbell W; Dawson T; Gill M; Hebing R; Meara A; Nieuwlaat R; Shaw Y; Singh JA; Suarez-Almazor M; Sumpton D; Wong P; Christensen R; Beaton D; de Wit M; Tugwell P;
Trials; 2018 Mar; 19(1):204. PubMed ID: 29587864
[TBL] [Abstract][Full Text] [Related]
9. Developing an OMERACT Core Outcome Set for Assessing Safety Components in Rheumatology Trials: The OMERACT Safety Working Group.
Klokker L; Tugwell P; Furst DE; Devoe D; Williamson P; Terwee CB; Suarez-Almazor ME; Strand V; Woodworth T; Leong AL; Goel N; Boers M; Brooks PM; Simon LS; Christensen R
J Rheumatol; 2017 Dec; 44(12):1916-1919. PubMed ID: 27744393
[TBL] [Abstract][Full Text] [Related]
10. OMERACT Endorsement of Patient-reported Outcome Instruments in Antineutrophil Cytoplasmic Antibody-associated Vasculitis.
Robson JC; Tomasson G; Milman N; Ashdown S; Boonen A; Casey GC; Cronholm PF; Cuthbertson D; Dawson J; Direskeneli H; Easley E; Kermani TA; Farrar JT; Gebhart D; Lanier G; Luqmani RA; Mahr A; McAlear CA; Peck J; Shea B; Shea JA; Sreih AG; Tugwell PS; Merkel PA
J Rheumatol; 2017 Oct; 44(10):1529-1535. PubMed ID: 28864650
[TBL] [Abstract][Full Text] [Related]
11. Toward Ensuring Health Equity: Readability and Cultural Equivalence of OMERACT Patient-reported Outcome Measures.
Petkovic J; Epstein J; Buchbinder R; Welch V; Rader T; Lyddiatt A; Clerehan R; Christensen R; Boonen A; Goel N; Maxwell LJ; Toupin-April K; De Wit M; Barton J; Flurey C; Jull J; Barnabe C; Sreih AG; Campbell W; Pohl C; Duruöz MT; Singh JA; Tugwell PS; Guillemin F
J Rheumatol; 2015 Dec; 42(12):2448-59. PubMed ID: 26077410
[TBL] [Abstract][Full Text] [Related]
12. Content and Construct Validity, Reliability, and Responsiveness of the Rheumatoid Arthritis Flare Questionnaire: OMERACT 2016 Workshop Report.
Bartlett SJ; Barbic SP; Bykerk VP; Choy EH; Alten R; Christensen R; den Broeder A; Fautrel B; Furst DE; Guillemin F; Hewlett S; Leong AL; Lyddiatt A; March L; Montie P; Pohl C; Scholte Voshaar M; Woodworth TG; Bingham CO
J Rheumatol; 2017 Oct; 44(10):1536-1543. PubMed ID: 28811351
[TBL] [Abstract][Full Text] [Related]
13. Can we decide which outcomes should be measured in every clinical trial? A scoping review of the existing conceptual frameworks and processes to develop core outcome sets.
Idzerda L; Rader T; Tugwell P; Boers M
J Rheumatol; 2014 May; 41(5):986-93. PubMed ID: 24584917
[TBL] [Abstract][Full Text] [Related]
14. Development of an extension of the OMERACT Summary of Measurement Properties table to capture equity considerations: SOMP-Equity.
Petkovic J; Umaefulam V; Wattiaux A; Bartels C; Barnabe C; Greer-Smith R; Hofstetter C; Maxwell L; Shea B; Barton J; Lee AYS; Humphreys J; Beaton D; Tugwell P
Semin Arthritis Rheum; 2021 Dec; 51(6):1300-1310. PubMed ID: 34625296
[TBL] [Abstract][Full Text] [Related]
15. Establishing a core domain set to measure rheumatoid arthritis flares: report of the OMERACT 11 RA flare Workshop.
Bykerk VP; Lie E; Bartlett SJ; Alten R; Boonen A; Christensen R; Furst DE; Hewlett S; Leong AL; Lyddiatt A; March L; May JE; Montie P; Orbai AM; Pohl C; Scholte Voshaar M; Woodworth T; Bingham CO; Choy EH
J Rheumatol; 2014 Apr; 41(4):799-809. PubMed ID: 24584927
[TBL] [Abstract][Full Text] [Related]
16. Toward the Development of a Core Set of Outcome Domains to Assess Shared Decision-making Interventions in Rheumatology: Results from an OMERACT Delphi Survey and Consensus Meeting.
Toupin-April K; Barton J; Fraenkel L; Li LC; Brooks P; De Wit M; Stacey D; Légaré F; Meara A; Shea B; Lyddiatt A; Hofstetter C; Gossec L; Christensen R; Scholte-Voshaar M; Suarez-Almazor ME; Boonen A; Meade T; March L; Pohl C; Jull JE; Sivarajah S; Campbell W; Alten R; Karuranga S; Morgan E; Kaufman J; Hill S; Maxwell LJ; Welch V; Beaton D; El-Miedany Y; Tugwell PS
J Rheumatol; 2017 Oct; 44(10):1544-1550. PubMed ID: 28765239
[TBL] [Abstract][Full Text] [Related]
17. Overview of the patient perspective at OMERACT 10--conceptualizing methods for developing patient-reported outcomes.
Kirwan JR; Tugwell PS
J Rheumatol; 2011 Aug; 38(8):1699-701. PubMed ID: 21807788
[TBL] [Abstract][Full Text] [Related]
18. Development of a Draft Core Set of Domains for Measuring Shared Decision Making in Osteoarthritis: An OMERACT Working Group on Shared Decision Making.
Toupin-April K; Barton J; Fraenkel L; Li L; Grandpierre V; Guillemin F; Rader T; Stacey D; Légaré F; Jull J; Petkovic J; Scholte-Voshaar M; Welch V; Lyddiatt A; Hofstetter C; De Wit M; March L; Meade T; Christensen R; Gaujoux-Viala C; Suarez-Almazor ME; Boonen A; Pohl C; Martin R; Tugwell PS
J Rheumatol; 2015 Dec; 42(12):2442-7. PubMed ID: 25877502
[TBL] [Abstract][Full Text] [Related]
19. Domains selection for patient-reported outcomes: current activities and options for future methods.
Tugwell PS; Petersson IF; Boers M; Gossec L; Kirwan JR; Rader T; Sanderson TC; van de Laar MA; Ueffing E; Witter JP
J Rheumatol; 2011 Aug; 38(8):1702-10. PubMed ID: 21807789
[TBL] [Abstract][Full Text] [Related]
20. Validating Rheumatoid Arthritis Remission Using the Patients' Perspective: Results from a Special Interest Group at OMERACT 2016.
Rasch LA; Boers M; Hill CL; Voshaar M; Hoogland W; de Wit M; Flurey C; Davis B; Hetland ML; Brahe CH; Gossec L; Wells GA; Tugwell P; Kuriya B; Goel N; Singh JA; Duarte C; Da Silva J; van Schaardenburg D; Proudman S; van Tuyl LHD;
J Rheumatol; 2017 Dec; 44(12):1889-1893. PubMed ID: 28765250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
